Animal medicines or "lead" prices mainstream

With the continuous expansion of the domestic health market, the market's demand for health Chinese herbal medicines has also grown. In many old health medicines, the proportion of animal medicines is not high, but with the increasing scarcity of animal medicines and their increasing demand, animal medicines will have strong developmental energy in the future market prospects. . Chinese leeches are valuable Chinese herbal medicines, which have the effects of swelling, blood stasis, and antiphlogistic detoxification. Moreover, leeches are not only highly medicinal but also have a wide range of applications.

Modern medical research and clinical evidence show that leech contains hirudin, heparin, anti-thromboxane, histamine-like substances, and is used clinically for the treatment of stroke, amenorrhea, angina pectoris, nameless swelling, bruises, hypertension, heart failure, multiple Cerebral thrombosis, myocardial infarction, acute thrombophlebitis, postpartum hemorrhage, cervical lymph node tuberculosis and other diseases, especially for high blood lipids, thrombosis have a good therapeutic effect. Since the medical efficacy of leeches is mainly in the cardiovascular and cerebrovascular aspects, a large number of leeches are being used to treat new drugs, special drugs and proprietary Chinese medicines for the elderly's cardiovascular and cerebrovascular diseases.

From precious medicinal snakes to common donkey-hide gelatins and bezoars, these animal medicines have shown rising prices in the recent market. “There are two reasons for this trend. One is the increasing demand for animal medicines in the market, and the other is the lack of animal medicines. It is scarce in itself.” Say.

There is a market for demand, and the lack of supply in the market leads to high prices for medicinal animals. Because the cost of energy, time, and other costs for animal breeding is higher than plant cultivation, most drug farmers choose to grow Chinese medicine instead of selecting pesticides, plus the ecology that is conducive to the survival of wild medicinal animals as the natural ecology continues to be destroyed. The environment gradually deteriorated and the number of wild medicinal animals gradually decreased. Therefore, there are many reasons that caused the medicinal Chinese herbal medicines for animals to be very scarce.

Take medicine snakes as an example. China's domestic and foreign markets for snakes (medicinal and edible) are dominated by wild products, with production accounting for about 90% of the consumption, and the rest for artificial breeding snakes. Prior to the 21st century, wild snakes had a good ecological environment, with reserves of at least 5000-10,000 tons. However, in the following years, due to improper hunting, the ecological balance and reproduction of snakes were greatly destroyed, and the production of wild snakes drastically decreased year by year; the production areas continued to carry out mountain development, mining, and road construction in order to develop the local economy. Many activities such as building bridges, building factories, and developing tourist areas have severely damaged the environment in which snakes live, and production has been greatly reduced.

Contrary to the reduced output, the demand for medicinal snakes in the domestic and international markets has continued to rise, and has increased at a rate of 10% to 15%. The great demand and the shortage of medicinal snakes have caused the current price increase in the medicinal snake market. Taking the example of snakes, black snakes and white snakes with the most market amount, the prices of these three snakes continued to rise in 2010, rising to 2,300 yuan, 220 yuan and 40 yuan respectively, setting a record for the price of medicinal snakes. The new high, and because of shortage of resources, weak stocks, increased shortfalls, and rising prices and wages throughout the country, the cost of catching snakes has risen. Therefore, the market price of medicinal snakes will inevitably continue to rise.

Pien Tze Huang and Dong E-Jiao are typical representatives of animal drugs. Since 2010, the two companies have repeatedly raised their product prices, and their price increases have increased significantly. Among them, Dong'e Ejiao has raised product prices four times in January, May, October and January 2011. In a recent price increase, Dong'e Ejiao stated that due to the continuous increase in the purchase price of donkey skin resources, Ejiao block products The ex-factory price does not increase by more than 60%. The Pien Tze Huang is not to be outdone. It has raised the price of the product three times in January 2010, January 2011 and October. The latest price increase has doubled. In the case of Pien Tze Huang from the last price increase for less than 10 months, Pien Tze Huang has again raised the selling price of the product since the 12th. The domestic price has been raised by RMB 40 per grain, and the export price has been increased by US$ 6 per grain.